Dashboard
Manage Tickers

CALC CalciMedica, Inc.

Nasdaq calcimedica.com


$ 3.19 $ -0.06 (-1.85 %)    

Thursday, 13-Nov-2025 09:34:05 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 611.02 $ -6.66 (-1.08 %)
DIA $ 478.71 $ -2.65 (-0.55 %)
SPY $ 675.61 $ -4.87 (-0.72 %)
TLT $ 89.78 $ -0.03 (-0.03 %)
GLD $ 387.04 $ -0.31 (-0.08 %)
$ 3.34
$ 3.19
$ 3.17 x 100
$ 3.31 x 100
$ 3.19 - $ 3.19
$ 1.42 - $ 4.26
33,797
na
46.67M
$ 0.80
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2025 09-30-2025 10-Q
2 08-12-2025 06-30-2025 10-Q
3 05-14-2025 03-31-2025 10-Q
4 03-27-2025 12-31-2024 10-K
5 11-13-2024 09-30-2024 10-Q
6 08-12-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-28-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-11-2023 06-30-2023 10-Q
11 05-12-2023 03-31-2023 10-Q
12 03-09-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-11-2022 06-30-2022 10-Q
15 05-11-2022 03-31-2022 10-Q
16 03-11-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-14-2021 03-31-2021 10-Q
20 03-05-2021 12-31-2020 10-K
21 11-12-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

calcimedica-q3-eps-052-misses-042-estimate
CalciMedica Q3 EPS $(0.52) Misses $(0.42) ...
11/12/2025 12:03:45

CalciMedica (NASDAQ:CALC) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.42)...

calcimedica-and-telperian-partner-to-integrate-ai-engine-for-analyzing-auxora-clinical-trials-refining-patient-targets-and-efficacy-endpoints
CalciMedica And Telperian Partner To Integ...
10/14/2025 11:05:27

calcimedica-q2-eps-040-misses-035-estimate
CalciMedica Q2 EPS $(0.40) Misses $(0.35) ...
08/12/2025 11:08:27

CalciMedica (NASDAQ:CALC) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.35)...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
08/01/2025 17:07:08

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/01/2025 12:07:59

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
07/11/2025 17:06:03

calcimedica-publishes-design-and-rationale-of-phase-2-kourage-trial-of-auxora-in-acute-kidney-injury-with-respiratory-failure-in-american-journal-of-nephrology
CalciMedica Publishes Design And Rationale...
06/25/2025 11:03:19

Publication includes previously announced preclinical data of Auxora™ in acute kidney injury (AKI) models as well as a post-hoc...

hc-wainwright--co-reiterates-buy-on-calcimedica-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Calc...
05/15/2025 11:13:09

HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $16 price tar...

calcimedica-q1-eps-036-misses-031-estimate
CalciMedica Q1 EPS $(0.36) Misses $(0.31) ...
05/14/2025 11:09:49

CalciMedica (NASDAQ:CALC) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.31)...

hc-wainwright--co-reiterates-buy-on-calcimedica-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Calc...
04/01/2025 11:15:45

HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $16 price tar...

calcimedica-announced-that-the-company-has-entered-into-a-credit-facility-with-avenue-venture-opportunities-fund-ii-lp-a-fund-of-avenue-capital-group-providing-up-to-325m
CalciMedica Announced That The Company Has...
03/05/2025 12:12:22

hc-wainwright--co-reiterates-buy-on-calcimedica-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Calc...
03/04/2025 13:18:57

HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $16 price tar...

calcimedica-presents-aki-data-from-a-post-hoc-analysis-of-the-phase-2-cardea-trial-of-auxora-in-severe-covid-19-pneumonia
CalciMedica Presents AKI Data From A Post-...
03/04/2025 12:27:22

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
01/02/2025 21:05:44

lucid-capital-markets-initiates-coverage-on-calcimedica-with-buy-rating-announces-price-target-of-13
LUCID CAPITAL MARKETS Initiates Coverage O...
12/17/2024 15:42:11

LUCID CAPITAL MARKETS analyst Dev Prasad initiates coverage on CalciMedica (NASDAQ:CALC) with a Buy rating and announces Pr...

hc-wainwright--co-reiterates-buy-on-calcimedica-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Calc...
11/14/2024 10:35:36

HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $16 price tar...

calcimedica-q3-2024-gaap-eps-050-inline-proforma-cash-cash-equivalents-and-short-term-investments-of-approximately-237m-which-is-expected-to-fund-current-operations-into-the-first-half-of-2026
CalciMedica Q3 2024 GAAP EPS $(0.50), Inli...
11/13/2024 12:16:23

CalciMedica (NASDAQ:CALC) reported quarterly losses of $(0.50) per share which met the analyst consensus estimate.

calcimedica-has-appointed-stephen-bardin-as-chief-financial-officer-and-the-planned-departure-of-daniel-geffken-interim-chief-financial-officer-upon-filing-the-companys-third-quarter-financial-statements
CalciMedica Has Appointed Stephen Bardin A...
11/07/2024 12:41:12

hc-wainwright--co-maintains-buy-on-calcimedica-lowers-price-target-to-16
HC Wainwright & Co. Maintains Buy on Calci...
11/04/2024 12:01:36

HC Wainwright & Co. analyst Joseph Pantginis maintains CalciMedica (NASDAQ:CALC) with a Buy and lowers the price target ...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
10/31/2024 16:34:06

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION